Local Effectiveness And Complications Of Neoadjuvant Therapy In Esophageal Squamous Cell Carcinoma: Radiotherapy Versus Chemoradiotherapy [eficácia Local E Complicações Da Terapêutica Neoadjuvante No Carcinoma Epidermóide Do Esôfago: Radioterapia Versus Radioterapia Associada à Quimioterapia]

Objective: To evaluate tumor responses to neoadjuvant therapy, according to the histopathological findings of surgical specimens of patients operated and treated for squamous cell carcinoma of the middle third and distal esophagus. Methods: We conducted a retrospective nonrandomized study including 97 patients distributed as follows: Group I - 81 (83.5%) underwent neoadjuvant radiation therapy, and group II - 16 (16.5%) underwent neoadjuvant radiotherapy and chemotherapy. A third group of 26 patients undergoing esophagectomy alone was used for comparison of postoperative complications. The characteristics of each patient (age, gender and race), tumor site, staging, and histological evaluation of treatment modalities were reviewed and analyzed. Tumor response to neoadjuvant therapy was evaluated by histopathology of the specimen. Results: There was no statistically significant differences regarding race, gender, age, staging and postoperative complications in patients in the three groups. Patients undergoing radiotherapy and neoadjuvant chemotherapy showed more satisfactory tumor reduction, with improved local efficacy when compared to the group only submitted to neoadjuvant radiotherapy. Conclusion: The study suggests that radiotherapy combined with chemotherapy was more efficient in reducing tumor site when compared to the group treated with radiotherapy. In addition, neoadjuvant therapy did not increase the postoperative complications when compared to patients undergoing surgery alone.384227231(2007) Coordenação De Prevenção E Vigilância De Câncer, , http://bvsms.saude.gov.br/bvs/publicacoes/estimativa_incidencia_cancer_2008.pdf, Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Insti-tuto Nacional de Câncer, Estimativas 2008: Incidência de câncer no Brasil. Rio de Janeiro: INCA, acessado em 25-02-2008Zacherl, J., Sendler, A., Stein, H.J., Ott, K., Feith, M., Jakesz, R., Current status of neoadjuvant therapy for adenocarcinoma of the distal esophagus (2003) World J Surg, 27 (9), pp. 1067-74Pearson, J.G., The present status and future potential of radiotherapy in the management of esophageal cancer (1977) Cancer, 39 (2 SUPPL.), pp. 882-90Urba, S.G., Orringer, M.B., Turrisi, A., Iannettoni, M., Forastiere, A., Strawderman, M., Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma (2001) J Clin Oncol, 19 (2), pp. 305-13Ancona, E., Ruol, A., Santi, S., Merigliano, S., Sileni, V.C., Koussis, H., Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone (2001) Cancer, 91 (11), pp. 2165-74Kesler, K.A., Helft, P.R., Werner, E.A., Jain, N.P., Brooks, J.A., Dewitt, J.M., A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone (2005) Ann Thorac Surg, 79 (4), pp. 1116-21Berger, A.C., Farma, J., Scott, W.J., Freedman, G., Weiner, L., Cheng, J.D., Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival (2005) J Clin Oncol, 23 (19), pp. 4330-4337Sobin, L.H., Wittekind, C., International Union Against Cancer (2002) TNM Classification of Malignant Tumours, , 6 th ed. New York: Wiley-LissPinotti, H.W., Subtotal esophagectomy by transmediastinal tunnel without thoracotomy (1977) AMB Rev Assoc Med Bras, 23 (11), pp. 395-398McKeown, K.C., Total three-stage oesphagectomy for câncer of the esophagus (1976) Br J Surg, 63 (4), pp. 259-62Donington, J.S., Miller, D.L., Allen, M.S., Deschamps, C., Nichols, F.C., Pairolero, P.C., Tumor response to induction chemoradiation: Influence on survival after esophagectomy (2003) Eur J Cardiothorac Surg, 24 (4), pp. 631-636. , discussion 636-7Malaisrie, S.C., Untch, B., Aranha, G.V., Mohideen, N., Hantel, A., Pickleman, J., Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer (2004) Arch Surg, 139 (5), pp. 532-538. , discussion 538-9Danilo, G., Corsi, P.R., Frimm, C.E., Fava, J., Câncer do esôfago: Compli-cações pós-operatórias imediatas e letalidade hospitalar (2004) Rev Col Bras Cir, 31 (1), pp. 2-9Bosset, J.F., Gignoux, M., Triboulet, J.P., Tiret, E., Mantion, G., Elias, D., Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus (1997) N Engl J Med, 337 (3), pp. 161-167Walsh, T.N., Noonan, N., Hollywood, D., Kelly, A., Keeling, N., Hennessy, T.P., A comparison of multimodal therapy and surgery for esophageal adenocarcinoma (1996) N Engl J Med, 335 (7), pp. 462-467Tercioti, V., Lopes, L.R., Coelho Neto, J.S., Andreollo, N.A., Aspectos atuais da terapêutica neoadjuvante no carcinoma epidermoide do esôfago. Revisão da literatura (2009) ABCD Arq Bras Cir Dig, 22 (1), pp. 33-40Tepper, J., Krasna, M.J., Niedzwiecki, D., Hollis, D., Reed, C.E., Goldberg, R., Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 (2008) J Clin Oncol, 26 (7), pp. 1086-92Jones, D.R., Detterbeck, F.C., Egan, T.M., Parker, L.A., Bernard, S.A., Tepper, J.E., Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus (1997) Ann Thorac Surg, 64 (1), pp. 185-91. , duscussion 191-2Hennequin, C., Gayet, B., Sauvanet, A., Blazy, A., Perniceni, T., Panis, Y., Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus (2001) Int J Rad Oncol Biol Phys, 49 (3), pp. 657-64Makary, M.A., Kiernan, P.D., Sheridan, M.J., Tonnesen, G., Hetrick, V., Vaughan, B., Multimodality treatment for esophageal cancer: The role of surgery and neoadjuvant therapy (2003) Am Surg, 69 (8), pp. 693-700. , discussion 700-2Reynolds, J.V., Muldoon, C., Hollywood, D., Ravi, N., Rowley, S., O'Byrne, K., Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer (2007) Ann Surg, 245 (5), pp. 707-16Yano, M., Inoue, M., Shiozaki, H., Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer (2002) Ann Thorac Cardiovasc Surg, 8 (3), pp. 123-30Kleinberg, L., Forastiere, A.A., Chemoradiation in the management of esophageal cancer (2007) J Clin Oncol, 25 (26), pp. 4110-4117Hyngstrom, J.R., Posner, M.C., Neoadjuvant strategies for the treatment of locally advanced esophageal cancer (2010) J Surg Oncol, 101 (4), pp. 299-30